Literature DB >> 34783231

Waiting for Actionable Evidence: Roflumilast or Azithromycin?

Jerry A Krishnan1, Richard K Albert2, Stephen I Rennard3.   

Abstract

Entities:  

Keywords:  RELIANCE; azithromycin; chronic obstructive pulmonary disease; roflumilast

Year:  2022        PMID： 34783231      PMCID： PMC8893970          DOI： 10.15326/jcopdf.2021.0272

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  8 in total

Review 1.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

Review 2.  Phosphodiesterase-4 inhibitor therapy for lung diseases.

Authors:  Bianca Beghè; Klaus F Rabe; Leonardo M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

Review 3.  Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.

Authors:  Gerard J Criner; Jean Bourbeau; Rebecca L Diekemper; Daniel R Ouellette; Donna Goodridge; Paul Hernandez; Kristen Curren; Meyer S Balter; Mohit Bhutani; Pat G Camp; Bartolome R Celli; Gail Dechman; Mark T Dransfield; Stanley B Fiel; Marilyn G Foreman; Nicola A Hanania; Belinda K Ireland; Nathaniel Marchetti; Darcy D Marciniuk; Richard A Mularski; Joseph Ornelas; Jeremy D Road; Michael K Stickland
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

4.  Comparative Effectiveness of Roflumilast and Azithromycin for the Treatment of Chronic Obstructive Pulmonary Disease.

Authors:  Jenny Lam; Ivy Tonnu-Mihara; Nicholas J Kenyon; Brooks T Kuhn
Journal:  Chronic Obstr Pulm Dis       Date:  2021-10-28

5.  Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.

Authors:  MeiLan K Han; Nabihah Tayob; Susan Murray; Mark T Dransfield; George Washko; Paul D Scanlon; Gerard J Criner; Richard Casaburi; John Connett; Stephen C Lazarus; Richard Albert; Prescott Woodruff; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

Review 6.  Chronic bronchitis and chronic obstructive pulmonary disease.

Authors:  Victor Kim; Gerard J Criner
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

7.  Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

Authors:  Jadwiga A Wedzicha; Peter M A Calverley; Richard K Albert; Antonio Anzueto; Gerard J Criner; John R Hurst; Marc Miravitlles; Alberto Papi; Klaus F Rabe; David Rigau; Pawel Sliwinski; Thomy Tonia; Jørgen Vestbo; Kevin C Wilson; Jerry A Krishnan
Journal:  Eur Respir J       Date:  2017-09-09       Impact factor: 16.671

8.  Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD.

Authors:  Stephen I Rennard; Peter M A Calverley; Udo M Goehring; Dirk Bredenbröker; Fernando J Martinez
Journal:  Respir Res       Date:  2011-01-27
  8 in total
  1 in total

1.  Journal Club: Biologics and Potential for Immune Modulation in Chronic Obstructive Lung Disease.

Authors:  Takudzwa Mkorombindo; Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2022-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.